51 filings
8-K
TLSI
TriSalus Life Sciences Inc
7 May 24
Departure of Directors or Certain Officers
4:01pm
8-K
TLSI
TriSalus Life Sciences Inc
30 Apr 24
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
5:00pm
8-K
TLSI
TriSalus Life Sciences Inc
15 Apr 24
Changes in Registrant's Certifying Accountant
5:43pm
8-K
TLSI
TriSalus Life Sciences Inc
1 Apr 24
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
8:05am
8-K
TLSI
TriSalus Life Sciences Inc
11 Mar 24
Results of Operations and Financial Condition
9:25pm
8-K
lrkvyb0m0d 0bn7if6wk
25 Jan 24
Departure of Directors or Certain Officers
5:19pm
8-K
9k4ab
5 Jan 24
Results of Operations and Financial Condition
4:28pm
8-K
np0k401x3rhnhofbn
14 Nov 23
TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
tesvbf2j93a
3 Oct 23
Standby Equity Purchase Agreement
6:01am
8-K
bratei8pgwy9 fw
1 Sep 23
Regulation FD Disclosure
4:01pm
8-K
1iv11pe 2lotu
16 Aug 23
Entry into a Material Definitive Agreement
4:37pm
8-K
a8fuctd92 95v4hr
9 Aug 23
Submission of Matters to a Vote of Security Holders
7:05am
8-K
upaj59jr
2 Aug 23
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
5:05pm
8-K
5zyge28za11qj 867j0
2 Aug 23
Other Events
7:05am
8-K
o9mspaskhg1chx
21 Jul 23
Other Events
7:00am
8-K
kr601ozxsi dziq
6 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
y99vs ilw5mna22wbe
30 Jun 23
Unregistered Sales of Equity Securities
4:10pm
8-K
s99p9i diij2pw6i9r3
21 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
y71pqpct36tid2 5itf
15 Jun 23
Entry into a Material Definitive Agreement
4:10pm
8-K
x7e xt4fao
12 Jun 23
Regulation FD Disclosure
7:05am